Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster manufacturing, shaking up the $150-bn obesity market ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Discover nutrition tips for managing and preventing obesity. Learn practical strategies for healthy eating, portion control, ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...